U.S. Marine and Shipping Stock News

In recent days, Arm Holdings has been swept up in a global semiconductor pullback, as sector-wide worries over AI-fueled valuations, export controls, and rising competition have pressured chip and AI-infrastructure stocks across Asia, Europe, and the U.S. At the same time, Arm’s push into data-center AI CPUs, its expanding AGI CPU customer list, and questions around enforcing export restrictions to China have sharpened the focus on how resilient its licensing and royalty model may be under...

Immunome (IMNM) is in focus after the FDA accepted its New Drug Application for varegacestat, an oral therapy for adults with desmoid tumors, supported by positive Phase 3 RINGSIDE trial data. See our latest analysis for Immunome. The FDA’s acceptance of Immunome’s NDA comes after a mixed period for the stock, with a 20.45% 1 month share price return but a 9.38% decline over three months. The 1 year total shareholder return of 110.96% points to strong longer term momentum. If this kind of...

UroGen Pharma (URGN) is back in focus after the FDA cleared its Investigational New Drug application for UGN-501, allowing the company to move ahead with a Phase 1 bladder cancer study. See our latest analysis for UroGen Pharma. Against this backdrop, UroGen Pharma’s share price has climbed strongly, with a 30-day share price return of 22.62% and a 90-day share price return of 78.48%, while the 1-year total shareholder return of 163.46% points to powerful momentum rather than a short-lived...

Halliburton (NYSE:HAL) has secured multi-year contracts from Saudi Aramco covering unconventional gas development and onshore oil activities. The work includes deployment of Saudi Arabia’s first intelligent fracturing platform as part of a major unconventional gas project. The agreements also span a multi-year integrated oilfield program across hundreds of planned wells. Halliburton will expand local manufacturing and workforce commitments to support these projects. For investors watching...

ArcBest (ARCB) has moved into focus after announcing a restructuring plan that includes a 2% workforce reduction, the closing of ten ABF Freight service centers, the consolidation of brands, and the booking of sizeable cash charges and non cash impairments. See our latest analysis for ArcBest. The restructuring news comes after a period of strong momentum for ArcBest, with the share price at $159.81 and a 90 day share price return of 34.7%, while the 1 year total shareholder return is...

Cousins Properties (CUZ) has drawn fresh attention after recent trading, with the stock closing at $31.76 and showing double digit gains over both the past month and the past three months. See our latest analysis for Cousins Properties. The recent share price move in Cousins Properties builds on stronger momentum, with a 30 day share price return of 14.62% and a 90 day share price return of 31.84%, alongside a 1 year total shareholder return of 18.07%. If recent gains in Cousins Properties...

ANI Pharmaceuticals has delivered a strong 139.1% return over the past 5 years, yet at around US$79.20 the valuation checks now suggest the stock is closer to fairly priced than obviously cheap. A 139.1% total return over 5 years indicates ANI Pharmaceuticals has already rewarded patient shareholders, so fresh buyers may be weighing how much of the story is reflected in the current price. Positive topline data from the SYNCHRONICITY trial can support expectations for the branded portfolio,...

The Fed’s renewed hawkish tone, paired with volatile energy prices and a firm labor market, is reshaping how investors think about interest rate risk. For U.S. regional banks, tighter policy can shift the balance between what they earn on loans and what they pay on deposits, while swings in inflation expectations influence funding costs and credit demand. This article uses a focused screener of mid sized lenders to highlight 3 regional bank stocks whose business profiles could be especially...

Bell Canada has completed its first direct to device satellite ground station to support AST SpaceMobile's network in Canada. AST SpaceMobile secured new regulatory approval in New Zealand, expanding its potential service footprint. The company is preparing for the launch of additional BlueBird satellites to build out its direct to device constellation. AST SpaceMobile (NasdaqGS:ASTS) is back in focus as it adds fresh infrastructure and regulatory pieces to its direct to device puzzle. The...

DoorDash (NasdaqGS:DASH) is seeking approval in New Mexico to deploy its autonomous delivery vehicle, Dot, for short-distance deliveries. The company is pursuing legislative changes that would allow these robots to operate on public roads across the state. The outcome could influence how quickly DoorDash rolls out similar technology in additional U.S. jurisdictions. DoorDash is best known for its food delivery platform, and the push to deploy Dot in New Mexico highlights how the company is...

Prudential Financial (PRU) is in the spotlight after reporting stronger than expected first quarter earnings, with firmer investment income, solid annuity and retirement demand, and management underscoring ongoing business transformation and retirement focused product expansion. See our latest analysis for Prudential Financial. The stronger first quarter update has arrived alongside a clear pick up in momentum, with Prudential Financial’s 30 day share price return of 11.27% and 90 day share...

Corcept Therapeutics has delivered very strong long term share price gains over the past five years, yet its latest valuation checks lean more cautious, leaving investors weighing a powerful performance track record against a weak overall value score. Corcept Therapeutics is up about 346.1% over five years, which puts the recent share price in the context of a very strong run already behind it. Progress with cortisol modulating drugs, including Lifyorli and the resubmitted relacorilant...

Geopolitics just moved back to the front of the market’s attention, with U.S. strikes on Iran, drone and missile attacks across the Gulf, and oil prices reacting sharply. When tensions spill into shipping lanes and supply chains, some stocks can gain new contracts or attention, while others face higher risks and costs. This article looks at how that mix of risk and opportunity connects to the latest Defense and Aerospace Stocks screener and highlights 3 stocks that appear positively exposed...

Arrowhead Pharmaceuticals (ARWR) has drawn investor attention after recent share price moves, with the stock up about 4.1% over the past day but down roughly 8.3% over the past month. See our latest analysis for Arrowhead Pharmaceuticals. The recent 1 day share price return of 4.1% comes after a softer 30 day share price return of 8.3% and a 9.6% share price return year to date. The 1 year total shareholder return of very large magnitude suggests Arrowhead Pharmaceuticals has already...

Bitdeer Technologies Group has broken ground on a new 187,000-square-foot advanced electronics manufacturing facility in Sparks, Nevada, marking a US$36 million move into domestic production of its SEALMINER computing hardware and creating 70 local jobs. This facility, set to augment Bitdeer’s existing U.S. data centers and innovation hub, signals a deeper commitment to U.S.-based, vertically integrated computing hardware manufacturing within Nevada’s growing tech ecosystem. Next, we’ll...

Abbott Laboratories (ABT) just posted Q2 2026 revenue of about US$12.6b with basic EPS of US$0.53, alongside trailing twelve month revenue of roughly US$46.6b and EPS of US$3.11. Over recent quarters the company has seen revenue move from about US$11.1b in Q2 2025 to US$12.6b in Q2 2026, while quarterly EPS shifted from US$1.02 to US$0.53. This sets up a results season where investors are likely to focus closely on how margins are holding up in the current mix of growth drivers. See our full...

AI trading signals put Kirby in focus Fresh AI generated trading signals around Kirby (KEX) have pushed the stock into the spotlight, with the models flagging neutral near and mid term readings, as well as a long term strong positive bias. The same signals highlight a mid channel oscillation pattern and outline a short setup with defined downside potential and limited indicated risk, along with suggested institutional style long, breakout, and hedging approaches. See our latest analysis for...

Matador Resources (MTDR) has drawn fresh investor attention after recent trading, with the stock last closing at $53.80. The move comes alongside mixed short term returns and a longer record of positive performance over multiple years. See our latest analysis for Matador Resources. Recent trading puts Matador Resources on a firmer footing, with a 7 day share price return of 4.79% and a 30 day share price return of 6.75%. However, the 90 day share price return declined 3.24%. Over the longer...

Dynex Capital has delivered a 60.9% return over the past three years, yet the stock still screens as undervalued on earnings multiples while scoring weakly on broader valuation checks. This leaves investors weighing how much of that performance is already reflected in the current US$13.33 share price. Over the past three years, Dynex Capital has returned 60.9%, which puts recent short-term moves into context as part of a longer period of shareholder gains. For a mortgage REIT like Dynex...

In the past week, Wells Fargo & Company reported stronger-than-expected second-quarter 2026 results, with net income of US$6,407 million and continued stock buybacks alongside a planned dividend increase, while also issuing several new senior unsecured fixed-income notes across maturities from 2030 to 2046. The bank coupled these financial updates with ongoing technology investments, including the rollout of its AI Teammate tool for wealth advisors, signaling an emphasis on digital...

With the Federal Reserve striking a tougher tone on inflation and markets bracing for the possibility of higher for longer interest rates, large cap value stocks are back in focus for investors looking for potentially steadier ground. The Large-Cap Value Stocks screener picks out bigger companies that combine relatively low valuations, solid balance sheets, and moderate risk. In a setting where inflation sits at 3.5% and the prospect of further rate hikes depends on each new data release,...

Oscar Health (OSCR) is back in focus after recent analyst reports cited substantial upward revisions in earnings estimates and a top Zacks Rank #1 rating, prompting fresh attention from both value and momentum investors. See our latest analysis for Oscar Health. The recent attention on Oscar Health has come alongside a sharp swing in momentum, with a 1-day share price return of 0.83% and a 7-day share price return down 4.72%, set against a 90-day share price return of 84.29% and a 1-year...

EchoStar CEO Hamid Akhavan has resigned, with leadership duties moving to Charles W. Ergen and Thomas A. Cullen. The change comes alongside a shift in EchoStar's strategic direction affecting how key business units are run. Investors are assessing what the new leadership structure could mean for culture, execution, and the company’s future focus. EchoStar, traded as NasdaqGS:ECHO, is entering a transition period at a time when its share price sits at $92.0. The stock is down 4.2% over the...

Intuitive Surgical (ISRG) has released its Q2 2026 numbers, with revenue of US$2.9 billion and basic EPS of US$2.31, set against trailing 12 month revenue of US$11.0 billion and EPS of US$8.84. Over recent quarters, the company has seen revenue move from US$2.44 billion in Q2 2025 to US$2.89 billion in Q2 2026, while quarterly EPS shifted from US$1.84 to US$2.31, with trailing earnings up 20.4% over the past year and 16.7% per year over the past five years. With a net profit margin of 28.4%...